Top 20 brands, latest PBS roundup

Top 20 leading Brands

Pharma in Focus & Mercurial reports on some interesting trends among the top 20 PBS products for the quarter of September 30. Figures released by the PBS show that Humira’s (adalimumab) dominance continues, while Eylea (afibercept) and Lucentis (ranibizumab) are neck and neck in second and third spot respectively. For more on this article click here.   Analytics […]

Mercurial rates highest for customer satisfaction!

  In a recent independent survey conducted across the Australian pharmaceutical industry, Mercurial rated highest for overall satisfaction, with a score of 86. We are proud to have received this feedback for which we would like to extend our thanks to all our clients. Our commitment  is to provide our clients with quality service, best practice analytics and mobile […]

Billion dollar surge in PBS YTD

Pharma in Focus & Mercurial reports on a turnaround in PBS spending growth since the slow down in July. The latest numbers for August show a significant higher flow of dollars is continuing. For more on this article click here. Analytics for these pharma in focus stories were generated using MiPortal, Mercurial’s cloud-based business intelligence & analytics platform. Click here […]